Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
Clinical trial NCT02104947 · COMPLETED
Trial details
- NCT number
- NCT02104947
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-06
- Primary completion
- 2016-07-25
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.